Influence of the dissolution medium on the release of dehydroepiandrosterone from lipophilic suppositories

1. Azarmi S. et al.: Current perspectives in dissolution testing of conventional and novel dosage forms. Int. J. Pharm., 328(1), 12, 2007.10.1016/j.ijpharm.2006.10.001Search in Google Scholar

2. Babar A., Fares H. M., Plakogiannis F. M.: In vitro release of testosterone from suppository bases and in vivo absorption studies in human males. J. Pharm. Sci., 82(4), 389, 1993.10.1002/jps.2600820411Search in Google Scholar

3. Beral V., Bull D., Reeves G.: Endometrial cancer and hormonereplacement therapy in the Million Women Study. Lancet, 365, 1543, 2005.Search in Google Scholar

4. Bergogne-Bérézin E., Bryskier A.: The suppository form of antibiotic administration: pharmacokinetics and clinical application.J. Antimicrob. Chemother., 43(2), 177, 1999.10.1093/jac/43.2.177Search in Google Scholar

5. Buster J.E., Casson P.R. (2000). Biology and use in therapeutic intervention. in Menopause: Biology and Pathobiology. Lobo R. A., Kelsey J. and Marcus R. (editors). San Diego: Academic Press; p 628.Search in Google Scholar

6. Casson P. R. et al.: Dehydroepiandrosterone (DHEA) replacement in postmenopausal women: Present status and future promise.Menopause, 4, 225, 1997.10.1097/00042192-199704040-00009Search in Google Scholar

7. Casson P. R. et al.: Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am.J. Obstet. Gynecol., 169, 1536, 1993.10.1016/0002-9378(93)90431-HSearch in Google Scholar

8. Casson P. R. et al.: Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril, 63(5), 1027, 1995.10.1016/S0015-0282(16)57542-6Search in Google Scholar

9. Castelo-Branco C. et al.: Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas, 52(Suppl. 1), 46, 2005.10.1016/j.maturitas.2005.06.014Search in Google Scholar

10. Chicco D. et al.: Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories. Int. J. Pharm., 189, 147, 1999.10.1016/S0378-5173(99)00247-1Search in Google Scholar

11. Czarnecki W., Kasperek R.: Patent RP Nr P337979 z 21.01.2000r.Biomed Wytwórnia Surowic i Szczepionek w Lublinie.Search in Google Scholar

12. Dal Zorro M. et al.: Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories.Pharmazie, 67(1), 37, 2012.Search in Google Scholar

13. Ghorab D., Refai H., Tag R.: Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Discov. Ther., 5(6), 311, 2011.10.5582/ddt.2011.v5.6.31122466443Search in Google Scholar

14. Hargoli S. et al.: Preparation and In vitro Evaluation of Naproxen Suppositories. Indian J. Pharm. Sci., 75(2), 143, 2013.Search in Google Scholar

15. Kalmár É. et al.: Novel sample preparation method for surfactant containing suppositories: effect of micelle formation on drug recovery. J. Pharm. Biomed. Anal., 83, 149, 2013.10.1016/j.jpba.2013.04.03923727364Search in Google Scholar

16. Karavana S. Y. et al.: Dissolution and histological studies on ordidazole vaginal formulation. Acta Pharma. Sci., 52, 430, 2010.Search in Google Scholar

17. Labrie F. et al.: Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause, 16(5), 923, 2009.10.1097/gme.0b013e31819e85c619424093Search in Google Scholar

18. Labrie F. et al.: Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric, 14(2), 282, 2011.10.3109/13697137.2010.53522621244215Search in Google Scholar

19. Labrie F. et al.: Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.Menopause, 16(5), 907, 2009.10.1097/gme.0b013e31819e8e2d19436225Search in Google Scholar

20. Labrie F. et al.: Is Dehydroepiandrosterone a hormone? J. Endocrinol., 187,169, 2005.10.1677/joe.1.0626416293766Search in Google Scholar

21. Labrie F. et al.: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab., 82, 2396, 1997.10.1210/jcem.82.8.41609253307Search in Google Scholar

22. Lynch C.: Vaginal estrogen therapy for the treatment of atrophic vaginitis. J. Womens Health (Larchmt), 18(10), 1595, 2009.10.1089/jwh.2008.128119788364Search in Google Scholar

23. Nestler J. E. et al.: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab., 66, 57, 1988.10.1210/jcem-66-1-572961787Search in Google Scholar

24. Niraj et al.: Effect of Adjuvants on the Release Pattern of Suppositories Containing Paracetamol. RJCES, 1(1), 19, 2013.Search in Google Scholar

25. Odeniyi M. A., Jaiyeoba K. T.: Effects of interacting variables on the release properties of chloroquine and aminophylline suppositories.Trop. J. Pharm. Res., 3(1), 285, 2004.10.4314/tjpr.v3i1.14611Search in Google Scholar

26. Panjari M., Davis S.R.: DHEA for postmenopausal women: a review of the evidence. Maturitas, 66(2), 172, 2010.10.1016/j.maturitas.2009.12.01720089375Search in Google Scholar

27. Panjari M., Davis S.R.: Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas, 70(1), 22, 2011.10.1016/j.maturitas.2011.06.00521733647Search in Google Scholar

28. Polish Pharmacopoeia IXth ed., vol. I, PTF Warsaw (2011).Search in Google Scholar

29. Realdon N. et al.: Effects of surfactant characteristics on drug availability from suppositories. Pharmazie, 63(6), 459, 2008.Search in Google Scholar

30. Sah M. L., Saini T.R.: Formulation development and release studies of indomethacin suppositories. Indian J. Pharm. Sci., 70(4), 498, 2008.10.4103/0250-474X.44602279255920046779Search in Google Scholar

31. Varshney H. M., Chatterjee A.: Formulation, evaluation and in-vitro release characteristics of zaltoprofen suppositories. Asian J. Pharm.Clin. Res., 5(4), 235, 2012.Search in Google Scholar

32. Varshney H. M., Tanwar Y. S.: Effect of different surfactants on the release pattern of cocoa butter suppositories containing flurbiprofen sodium. Acta Pharm. Sci., 52, 129, 2010.Search in Google Scholar

33. Verma P. et al.: Routes of drug administration. Int. J. Pharm. Studies Res., 1(1), 54, 2010.Search in Google Scholar